Skip to main content
. 2020 Jun 18;11(6):472. doi: 10.1038/s41419-020-2581-2

Fig. 1. DLEU2 is a novel LSCC-related oncogene and predicts the prognosis in LSCC patients.

Fig. 1

a Schematic depicting key lncRNAs and hub genes in the LRSP subpathways and network. b Topology features of the key lncRNAs. c DLEU2 and its potential target genes (PIK3CD, PPP1CC, and PPP3R1) were significantly upregulated in the tumor tissues compared with the normal control tissues in HNSCC patients from the TCGA database. d The mRNA expression of DLEU2 was evaluated by qRT-PCR analysis in 66 cases of LSCC specimens and the matched adjacent normal tissues. e–h Correlations of DLEU2 expression with the clinicopathological characteristics of the tumor stage (e), lymph node metastasis (f), tumor node metastasis (g), and differentiation (h) in LSCC specimens. i The correlation between survival time and DLEU2 expression was analyzed in LSCC patients. **P < 0.01, ***P < 0.001.